Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
8 Jul 2026
ESHRE 2026: HA-Enriched Medium Shows No IVF Benefit
A multicentre randomised trial presented at ESHRE 2026 found that HA-enriched embryo transfer medium did not significantly improve live birth or pregnancy outcomes in women undergoing single blastocyst transfer, questioning its routine use in IVF.
9
Mins
8 Jul 2026
Immune Surveillance in Haematology: Interview with Simona Pagliuca
It is actually something I have found myself reflecting on quite often recently, especially when speaking with students, residents, and…
AstraZeneca bets $200m on Chinese COPD drug
The company has agreed to pay a subsidiary of Sino Biopharmaceutical $200 for an experimental COPD drug.
8 Jul 2026
Physical Activity Linked to Healthier Metabolome and Cardiac Function
New evidence suggests regular physical activity was linked to beneficial metabolomic differences and greater cardiac parasympathetic modulation in healthy men.
3
Mins
8 Jul 2026
The Evolving Landscape of Sickle Cell Disease: Interview with Nicola Conran
Ever since I was an undergraduate, I have been fascinated by blood cells and how they respond immediately to biological events, driving…
5
Mins
8 Jul 2026
Hepatic Focal Fatty Sparing in Advanced Chronic Liver Disease: Clinical Outcomes of Cross-Sectional Imaging
Although benign, FFS can mimic true focal liver lesions, raising concern for hepatocellular carcinoma (HCC) or metastasis. The…
8 Jul 2026
Sarcopenia Affects Nearly 1 in 5 with Rheumatoid Arthritis
New research finds sarcopenia affects 18.6% of rheumatoid arthritis patients, with some biologic drugs linked to a lower risk of muscle loss.
GLP-1s: Cannes, culture and lessons from oncology
Claire Gillis, CEO, VML Health, explores how GLP-1s could transform medicine, echoing the cancer care revolution.
8 Jul 2026
Oral GP-SOD Boosts UVB Phototherapy Outcomes in Vitiligo
Adding oral GP-SOD to targeted UVB phototherapy significantly improved repigmentation and quality of life in patients with localized vitiligo.
8 Jul 2026
Onc Now: Cancer Vaccines and the Future of Immunotherapy
In this episode of Onc Now, Mary Disis, Director of the University of Washington’s Medicine Cancer Vaccine Institute, Seattle, USA, explores..
←
1
2
3
…
10
11
12
13
14
15
16
…
1,528
1,529
1,530
→
We’ve noticed you’re accessing
from
North/South America.
View
View